Stock listing

SVA Stock Price, News, Filings & Events — Sinovac Biotech, Ltd.

Selected listing: SVA · NASDAQ · USD · US

This page tracks Sinovac Biotech, Ltd.'s SVA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SVA:NASDAQ. SVA:NASDAQ is the stock-level entry point for investors researching Sinovac Biotech, Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Sinovac Biotech, Ltd. is a public company traded under the ticker SVA in the American market. The company has a market capitalization of approximately $464.9 million. Sinovac focuses on the development and commercialization of vaccines and biopharmaceutical products.

SVA:NASDAQUSDUSUpdated July 31, 2026
Sinovac Biotech, Ltd. logo
Ticker
SVA:NASDAQ
Asset type
Stock
Market cap
$464.9M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Sinovac Biotech, Ltd. SVA:NASDAQ stock context

This page tracks Sinovac Biotech, Ltd.'s SVA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SVA:NASDAQ. SVA:NASDAQ is the stock-level entry point for investors researching Sinovac Biotech, Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Sinovac Biotech, Ltd. is a public company traded under the ticker SVA in the American market. The company has a market capitalization of approximately $464.9 million. Sinovac focuses on the development and commercialization of vaccines and biopharmaceutical products.

Research Sinovac Biotech, Ltd.

Alternate listings